IntrinsicIntrinsic
OverviewFinancialsChartBusiness SummaryFilingsOwnershipValuation

Recent Updates — PRFX

September 9, 2026View Source ↗

PRF Technologies announced the establishment of GridFeed as a standalone subsidiary to pursue strategic alliances for its AI-driven renewable energy trading platform. This structural change aims to facilitate direct partnerships and investments with energy producers, traders, and utilities. The company highlighted recent technological validations, including acceptance into the NVIDIA Connect program and a patent filing for microclimate forecasting technology. PRF reported approximately $11.6 million in cash at the end of Q2 2026 while continuing healthcare development. PRF Technologies operates in the pharmaceutical and artificial intelligence sectors, developing extended-release therapeutics and AI-driven energy optimization software.

September 3, 2026View Source ↗

PRF Technologies Ltd. reported unaudited financial results for the six months ended June 30, 2026, recording a net loss of $2.8 million compared to $2.3 million in the prior year period. The company raised approximately $10.4 million through equity financing activities, including the full utilization of a May Standby Equity Purchase Agreement (SEPA) with Yorkville for $10.0 million and initial draws under a June SEPA totaling $447,000. Cash and equivalents increased to $8.5 million as of June 30, 2026. Operationally, the company received FDA clearance for its IND application for OcuRing™-K, enabling Phase II trial enrollment in late 2026, while PRF-110 demonstrated analgesic activity comparable to ZYNRELEF® in preclinical studies. DeepSolar generated early revenue from commercial engagements and unveiled new AI platforms. The company operates in the specialty pharmaceuticals and AI-driven energy analytics sectors.

July 27, 2026View Source ↗

PRF Technologies raised $10 million through an equity line facility on May 28, 2026, to strengthen its balance sheet. The company's biotechnology subsidiary, LayerBio, is preparing for a Phase 2 clinical trial of OcuRing™-K, while its renewable energy platform, DeepSolar, has validated its Predict™ platform with European market data. PRF Technologies operates in the biotechnology and renewable energy sectors through its dual business model of drug-delivery systems and AI-driven energy optimization technologies.

July 15, 2026View Source ↗

On July 15, 2026, PRF Technologies Ltd. announced an expansion of its DeepSolar Predict™ platform. The update introduces Battery-to-Revenue Intelligence, which aims to extend AI-driven revenue optimization capabilities to include both solar and energy storage assets. PRF Technologies Ltd. provides AI-driven software solutions for the solar and energy storage industries.